AJMC Staff


Reactivation of Hepatitis B After Ruxolitinib for MPN Hinges on Antivirals

July 24, 2021

The issue of reactivating hepatitis B and other chronic viruses such as herpes zoster after treatment for myeloproliferative neoplasms (MPN) is an emerging issue in hematologic malignancies, due to the power of newer therapies.